DOI: 10.1101/493221Dec 19, 2018Paper

Adaptation of Acinetobacter baumannii to colistin exposure: Laboratory mimicking of a clinical case

BioRxiv : the Preprint Server for Biology
Ezgi OralkanFusun Can


Adaptation of Acinetobacter baumannii to colistin use on a disease course of a patient was described. Effects of colistin was mimicked in the laboratory conditions. The colistin resistant isolate was identified from the patient after 25 days of colistin treatment. In the laboratory, the expressions of pmrCAB were the highest at the generation which was corresponded to the duration of therapy. A. baumannii can develop a stable colistin-resistant phenotype after three weeks of colistin exposure.

Related Concepts

Acinetobacter baumannii
Protein Expression
Isolate - Microorganism

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

The Journal of Antimicrobial Chemotherapy
Yoon-Kyoung HongKwan Soo Ko
Journal of Neurosurgery
Nikolaos Sakellaridis, Vasilios Kontoyannis
© 2021 Meta ULC. All rights reserved